DEVELOPMENT AND VALIDATION OF A CHROMATOGRAPHIC ASSAY METHOD FOR THE DETERMINATION OF LULICONAZOLE IN CREAMS

被引:3
作者
Gummadi, S. [1 ]
Kommoju, M. [1 ]
机构
[1] GITAM Deemed Be Univ, GITAM Inst Pharm, Dept Pharmaceut Anal, Visakhapatnam 530045, Andhra Pradesh, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2020年 / 11卷 / 09期
关键词
Luliconazole; Binary gradient HPLC; Validation; ICH Guidelines Stability-indicating;
D O I
10.13040/IJPSR.0975-8232.11(9).4622-28
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simple and rapid reverse-phase high-performance liquid chromatographic technique was developed and validated for the determination of Luliconazole in the presence of its excipients. Chromatographic elution was performed on a binary gradient HPLC equipped with PDA detector using a Luna-5 mu C8(2) 100 angstrom column (250 x 4.6 mm, 5 mu m) with orthophosphoric acid (0.1%) and methanol (20:80% w/v) as mobile phase at a flow rate of 1.2 mL/min. The method follows Beer-Lambert's law over a concentration range 0.1-200 mu g/mL (y = 53981x + 25076, R-2 = 0.999). The LOD and LOQ were found to be 0.068 mu g/mL and 0.206 mu g/mL indicating the sensitivity of the method with the required precision and accuracy. The method proved to be specific as there was no interference from the commonly used excipients in a formulation like methylparaben and also in the presence of degradants when exposed to a variety of stress conditions (acidic, alkaline, oxidation, thermal, hydrolytic and photolytic degradations). It was observed that Luliconazole was more sensitive towards alkaline conditions, and hence the proposed method, validated as per ICH guidelines proved to be stability-indicating and can be successfully applied for the determination of Luliconazole in creams.
引用
收藏
页码:4622 / 4628
页数:7
相关论文
共 14 条
  • [1] [Anonymous], ICH HARM TRIP GUID S
  • [2] [Anonymous], 2003, STAB TEST NEW DRUG S
  • [3] [Anonymous], 2005, ICH HARM TRIP GUID V
  • [4] Chaudhari MJ, 2018, ASIAN J PHARM ANAL, V8, P45
  • [5] Guidelines of care for superficial mycotic infections of the skin: Tinea corporis, Tinea cruris, Tinea faciei, Tinea manuum, and Tinea pedis
    Drake, LA
    Dinehart, SM
    Farmer, ER
    Goltz, RW
    Graham, GF
    Hordinsky, MK
    Lewis, CW
    Pariser, DM
    Skouge, JW
    Webster, SB
    Whitaker, DC
    Butler, B
    Lowery, BJ
    Elewski, BE
    Elgart, ML
    Jacobs, PH
    Lesher, JL
    Scher, RK
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (02) : 282 - 286
  • [6] Jarratt M, 2013, CUTIS, V91, P203
  • [7] In vitro antifungal activities of luliconazole, a new topical imidazole
    Koga, Hiroyasu
    Nanjoh, Yasuko
    Makimura, Koichi
    Tsuboi, Ryoji
    [J]. MEDICAL MYCOLOGY, 2009, 47 (06) : 640 - 647
  • [8] Malasiya A., 2017, Int. J. Pharmaceut. Chem. Anal., V4, P46, DOI [10.18231/2394-2797.2017.0012, DOI 10.18231/2394-2797.2017.0012]
  • [9] Marek AW, 2013, DEV LC MS MS METHOD
  • [10] Inhibition of sterol 14 α-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent
    Niwano, Y
    Koga, H
    Kodama, H
    Kanai, K
    Miyazaki, T
    Yamaguchi, H
    [J]. MEDICAL MYCOLOGY, 1999, 37 (05) : 351 - 355